Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Open Access
- 24 March 2023
- journal article
- research article
- Published by Springer Nature in Diabetes Therapy
- Vol. 14 (5) , 937-945
Abstract
Glucocorticoids, also known as steroids, are a class of anti-inflammatory drugs utilised widely in clinical practice for a variety of conditions. They are associated with a range of side effects including abnormalities of glucose metabolism. Multiple guidelines have been published to illustrate best management of glucocorticoid-induced hyperglycaemia and diabetes in a variety of settings. This article discusses current best clinical practice including diagnosis, investigations and ongoing management of glucocorticoid-induced dysglycaemia in both in- and outpatient settings.Keywords
This publication has 20 references indexed in Scilit:
- Steroid-induced hyperglycaemia in primary careLondon Journal of Primary Care, 2015
- Monitoring of Patients on Long-Term Glucocorticoid TherapyMedicine, 2015
- Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative reviewWorld Journal of Diabetes, 2015
- Hyperglycemia Induced by Glucocorticoids in Nondiabetic Patients: A Meta-AnalysisAnnals of Nutrition and Metabolism, 2014
- How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoid treatment?Clinical Medicine, 2014
- Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort studyBMJ, 2012
- Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes?ISRN Endocrinology, 2012
- Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsRheumatology, 2011
- Risk of Diabetes Associated With Prescribed Glucocorticoids in a Large PopulationDiabetes Care, 2006
- Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderlyJournal of General Internal Medicine, 2002